Clinical Trials
Search our team at AdventHealth Research Institute
Showing 1 - 4 of 4 clinical trials matching your search
-
NCT03671889
Assessment of Safety and Efficacy of Exablate Blood-Brain Barrier Disruption for the Treatment of Patients with Probable Alzheimer’s Disease
This study is currently enrolling.Associated Conditions: Brain Health - MemoryResearch Area: Neuroscience ResearchResearch Location: CelebrationThe result of this study will help us determine whether blood-brain barrier disruption (BBBD) with Exablate is a safe procedure in the brains of patients with Alzheimer’s Disease. The purpose of this...
-
NCT06170268
Alzheimer’s Association / “Alzheimer’s Network for Treatment and Diagnostics (ALZ-NET)”.
This study is currently enrolling.Associated Conditions: Brain Health - MemoryResearch Area: Neuroscience ResearchResearch Location: Orlando -
NCT04408625
A Phase 1/2 Ascending Dose Study to Evaluate the Safety and Effects on Progranulin Levels of LY3884963 in Patients with Fronto-Temporal Dementia with Progranulin Mutations (FTD-GRN) (PROCLAIM)
This study is currently enrolling.Associated Conditions: Brain Health - MemoryResearch Area: Neuroscience ResearchResearch Location: OrlandoThe purpose of this open label study is to assess the safety, tolerability, and effects of LY3884963 on plasma (the liquid component of blood) and/or cerebrospinal fluid (CSF; fluid from the area...
-
NCT06189963
NKGen Biotech, Inc. “A Phase 1/2a Study to Evaluate the Safety, Tolerability and Exploratory Efficacy of SNK01 in Participants with Moderate Alzheimer’s Disease (Study SNK01-AD01)”
This study is currently enrolling.Associated Conditions: Brain Health - MemoryResearch Area: Neuroscience ResearchResearch Location: OrlandoThe primary purpose of this research is to evaluate the safety of NK cell therapy when given alone. A secondary objective is to evaluate any preliminary efficacy by the change in cognitive assessment...